Literature DB >> 36055726

Neuropsychiatric Model of Addiction Simplified.

Wilson M Compton1, Eric M Wargo2, Nora D Volkow2.   

Abstract

While substance experimentation typically begins in adolescence, substance use disorders (SUDs) usually develop in late teens or early adulthood, often in individuals who are vulnerable because of biological and socioeconomic risk factors. Severe SUDs-synonymous with addiction-involve changes in limbic and prefrontal brain areas after chronic drug exposure. These changes involve learned associations between drug reward and cues that trigger the anticipation of that reward (known as incentive salience), as well as heightened dysphoria during withdrawal and weakened prefrontal circuits needed for inhibiting habitual responses. Published by Elsevier Inc.

Entities:  

Keywords:  Addiction; Addiction cycle; Neurobiology; Reinforcement

Mesh:

Year:  2022        PMID: 36055726      PMCID: PMC9450117          DOI: 10.1016/j.psc.2022.05.001

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  65 in total

Review 1.  Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation.

Authors:  A T McLellan; D C Lewis; C P O'Brien; H D Kleber
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

2.  Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain.

Authors:  J OLDS; P MILNER
Journal:  J Comp Physiol Psychol       Date:  1954-12

3.  Emergency Department Visits and Overdose Deaths From Combined Use of Opioids and Benzodiazepines.

Authors:  Christopher M Jones; Jana K McAninch
Journal:  Am J Prev Med       Date:  2015-07-03       Impact factor: 5.043

Review 4.  The Actin Cytoskeleton as a Therapeutic Target for the Prevention of Relapse to Methamphetamine Use.

Authors:  Erica J Young; Sherri B Briggs; Courtney A Miller
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

Review 5.  The Gateway Hypothesis of substance abuse: developmental, biological and societal perspectives.

Authors:  Denise Kandel; Eric Kandel
Journal:  Acta Paediatr       Date:  2014-12-02       Impact factor: 2.299

6.  MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.

Authors:  Christopher D Verrico; Gregory M Miller; Bertha K Madras
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

Review 7.  NOW vs LATER brain circuits: implications for obesity and addiction.

Authors:  Nora D Volkow; Ruben D Baler
Journal:  Trends Neurosci       Date:  2015-05-07       Impact factor: 13.837

8.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Yonette F Thomas; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-05

Review 9.  Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction.

Authors:  David Belin; Sietse Jonkman; Anthony Dickinson; Trevor W Robbins; Barry J Everitt
Journal:  Behav Brain Res       Date:  2008-10-04       Impact factor: 3.332

Review 10.  Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse.

Authors:  Esa R Korpi; Bjørnar den Hollander; Usman Farooq; Elena Vashchinkina; Ramamoorthy Rajkumar; David J Nutt; Petri Hyytiä; Gavin S Dawe
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.